BDRX

Biodexa Pharmaceuticals
BDRX

Overview Fund Activity

4 hedge funds and large institutions have $17K invested in Biodexa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GI
1
GAMMA Investing
California
$10.3K
2
SS
2
SBI Securities
Japan
$4.9K

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$1.72K
2
Morgan Stanley
2
Morgan Stanley
New York
$0
3
RhumbLine Advisers
3
RhumbLine Advisers
Massachusetts
$59
4
CIM
4
Contravisory Investment Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GI
1
GAMMA Investing
California
$10.3K +$9.09K +1,051 +735%
SS
2
SBI Securities
Japan
$4.9K +$4.9K +567 New
UBS Group
3
UBS Group
Switzerland
$1.72K -$14.6K -1,684 -89%
RhumbLine Advisers
4
RhumbLine Advisers
Massachusetts
$59 -$211 -25 -78%
Morgan Stanley
5
Morgan Stanley
New York
– -$924 -70 Closed
CIM
6
Contravisory Investment Management
Massachusetts
– -$53 -4 Closed